Search
Capra hircus hair
go.drugbank.com/drugs/DB10876ApprovedDomestic goat hair is used in allergenic testing.
Categories: Non-Standardized Animal Hair Allergenic ExtractEquus caballus hair
go.drugbank.com/drugs/DB10880ApprovedHorse hair is used in allergenic testing.
Categories: Non-Standardized Animal Hair Allergenic ExtractForetinib
go.drugbank.com/drugs/DB12307InvestigationalIt inhibits the activation of MET, RON, ERK and AKT, decreased proliferation and increased apoptosis.
Adefovir dipivoxil
go.drugbank.com/drugs/DB00718ApprovedAdefovir dipivoxil, previously called bis-POM PMEA, with trade names Preveon and Hepsera, is an orally-administered acyclic nucleotide analog reverse transcriptase inhibitor (ntRTI) used for treatment of hepatitis B. It is ineffective ag...
Bosutinib
go.drugbank.com/drugs/DB06616ApprovedInvestigationalABL ratio on an international scale, with bosutinib treatment. … [L48436] On September 26, 2023, bosutinib was also approved by the FDA for the treatment of pediatric CML that is newly diagnosed or resistant/intolerant to prior therapy.
Elagolix
go.drugbank.com/drugs/DB11979ApprovedInvestigationalpriority review [F815], this expedited new approval gives healthcare professionals another valuable option for treating the potentially unmet needs of women who are affected by endometriosis, depending on
Polycarbophil
go.drugbank.com/drugs/DB09311ApprovedWithdrawnPolycarbophil calcium is a synthetic polymer manufactured from the cross-linking of polyacrylic acid with divinyl glycol and a calcium counter-ion.
Belladonna
go.drugbank.com/drugs/DB13913Approved[DB00572] is a non-selective muscarinic antagonist that is mainly used as an adjunct for anaesthesia.
Isopropyl beta-D-thiogalactopyranoside
go.drugbank.com/drugs/DB01862ExperimentalA non-metabolizable galactose analog that induces expression of the LAC operon.
Nerandomilast
go.drugbank.com/drugs/DB18237ApprovedInvestigational[L54126] On October 7, 2025, nerandomilast was approved as the first new treatment for idiopathic pulmonary fibrosis in more than a decade. … [A274581] On December 19, 2025, the U.S. FDA approved nerandomilast tablets for the treatment of progressive pulmonary fibrosis (PPF) in adults.